PK & DistributionBioanalysisVectors & gene therapy distributionBiomarker studies
Tinnitus detectionGPIAS & PPIHyperacusis
TranstympanicIntracochlearSystemic
Inner ear surgeryCochlear implantationBrain Electrode implantationOther otic surgery
In vitro on Otic cell lineEx vivo on Cochlear explantsIn vivo in Zebrafish
Formulation for otic delivery
Noise-induced hearing lossSynaptopathyCisplatin-induced ototoxicityAntibiotic-induced ototoxicityOuabain-induced auditory neuropathySalicylate-induced tinnitusOther disease & transgenic modelsRodent & large species
Auditory efficacy studiesAuditory tolerance & safety studiesAuditory phenotyping studiesGLP Ototoxicity studies / GLP Toxicology & Toxicokinetics
Small molecules, peptides, antibodies, large moleculesGene & cell therapiesCochlear implants, implantable devices, drug-eluting electrodes
ABRDPOAEWave I to V analysisCAP & unicellular electrophysiology
OtoscopyTympanometryGross middle ear assessment
Histology of the earCytocochleogramHistology of other organsMicroscopy & imaging
BiochemistryMolecular biology
CILcare will participate to the Tinnitus Research Initiative (TRI) at Ann Harbor June 7-10, 2015
Meet us !